Searched for
PRE EXPOSURE PROPHYLAXIS
Dr Reddy's inks pact with Gilead for once-yearly HIV prevention drug lenacapavirDr Reddy's Laboratories and Gilead Sciences have signed a licensing agreement. This pact involves investigational once-yearly lenacapavir f...- DRL, Emcure get approval to make breakthrough HIV drugIndia's drug regulator has cleared the path for local lenacapavir manufacturing. Two Indian pharmaceutical companies received waivers for l...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- HIV-prevention drug to cost $40 a year from 2027The two organizations have signed separate agreements with Indian pharmaceutical companies to produce cheaper generics of lenacapavir - a t...
- Lenacapavir HIV shot approved in US may enter Canada by 2026; just two injections needed a yearA twice-yearly injectable drug, lenacapavir, hailed as a breakthrough in HIV prevention, could be available in Canada by mid-2026. Develope...
- US approves Gilead's twice-yearly injection to prevent HIVThe US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move the company hail...
- Activists sound alarm bells as Gilead seeks rights over HIV drugLenacapavir, a very expensive drug, is not available in India and many other countries. If the Indian Patent Office clears Gilead's patent ...
- European Commission authorises GSK's HIV prevention drugCabotegravir is recommended in combination with safer sex practices for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually-acqu...
- Aurobindo, Cipla, Viatris in licensing pact with MPP to make ViiV's HIV preventive therapyThrough the MPP-ViiV Healthcare agreement, the three generic manufacturers will be able to develop, manufacture, and supply generic version...
- The changing tides of time, how life with HIV is no longer a death sentenceLiving with HIV is as simple as taking a single pill a day to keep the virus undetectable in your blood.
- Molnupiravir authorisation comes with a condition - further trials in the next three monthsAccording to one of the conditions, as post marketing surveillance the companies will have to submit periodic safety update reports to the ...
- USFDA study shows Evusheld retains neutralising activity against Omicron: AstraZenecaEvusheld is the first long-acting antibody to receive emergency use authorisation in the US for pre-exposure prophylaxis of COVID-19, in ad...
- AstraZeneca adds 2.5% after initiating talks on Covid prevention drug with Indian authoritiesEvusheld, a Covid-19 prevention drug for individuals with weakened immune systems, has received emergency use authorisation in the US.
- AZ to seek India nod for antibody cocktailEvusheld is a combination of tixagevimab and cilgavimab. The drug received EUA in the US on Thursday for pre-exposure prophylaxis or preven...
- AstraZeneca in touch with Indian authorities for approval to COVID drugThe company also said studies are underway to provide information on the impact of the new Omicron variant on Evusheld, which is being deve...
- Lupin launches generic HIV-1 drug in USThe drug maker's product is the generic version of Gilead Sciences, Inc's Truvada tablets and indicated in combination with other antiretro...
- Lupin gets USFDA nod to market generic HIV drugThe company has received approval from the United States Food and Drug Administration (USFDA) to market its Emtricitabine and Tenofovir Dis...
- WHO ending hydroxycholorquine trial for COVIDWHO says a review of the interim results showed hydroxychloroquine and lopinavir/ritonavir "produce little or no reduction in the mortality...
- Zydus Cadila receives DCGI nod to market rabies drug in IndiaZydus said it currently also manufactures and markets the rabies vaccine — VaxiRab.
- Anti-AIDS medicine project likely to take off at SonagachiUnder the project PrEP, regular medicine would be given to an HIV-negative sex worker engaged in sex with an HIV-positive person.
Load More
